Form 8-K - Current report:
SEC Accession No. 0001104659-25-060714
Filing Date
2025-06-18
Accepted
2025-06-18 17:28:58
Documents
34
Period of Report
2025-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518203d1_8k.htm   iXBRL 8-K 232313
2 EXHIBIT 2.4 tm2518203d1_ex2-4.htm EX-2.4 22919
3 EXHIBIT 3.1 tm2518203d1_ex3-1.htm EX-3.1 6909
4 EXHIBIT 3.2 tm2518203d1_ex3-2.htm EX-3.2 8929
5 EXHIBIT 3.3 tm2518203d1_ex3-3.htm EX-3.3 5543
6 EXHIBIT 3.4 tm2518203d1_ex3-4.htm EX-3.4 243328
7 EXHIBIT 3.5 tm2518203d1_ex3-5.htm EX-3.5 88207
8 EXHIBIT 3.6 tm2518203d1_ex3-6.htm EX-3.6 79864
9 EXHIBIT 10.5 tm2518203d1_ex10-5.htm EX-10.5 56637
10 EXHIBIT 10.7 tm2518203d1_ex10-7.htm EX-10.7 122523
11 EXHIBIT 10.8 tm2518203d1_ex10-8.htm EX-10.8 99505
12 EXHIBIT 10.20 tm2518203d1_ex10-20.htm EX-10.20 137321
13 EXHIBIT 14.1 tm2518203d1_ex14-1.htm EX-14.1 73526
14 EXHIBIT 16.1 tm2518203d1_ex16-1.htm EX-16.1 2020
15 EXHIBIT 21.1 tm2518203d1_ex21-1.htm EX-21.1 1862
16 EXHIBIT 99.1 tm2518203d1_ex99-1.htm EX-99.1 15258
17 EXHIBIT 99.2 tm2518203d1_ex99-2.htm EX-99.2 312682
18 EXHIBIT 99.3 tm2518203d1_ex99-3.htm EX-99.3 170690
19 EXHIBIT 99.4 tm2518203d1_ex99-4.htm EX-99.4 254286
24 GRAPHIC tm2518203d1_ex14-1img01.jpg GRAPHIC 27308
25 GRAPHIC tm2518203d1_ex3-4.jpg GRAPHIC 25895
26 GRAPHIC tm2518203d1_ex99-1img003.jpg GRAPHIC 3539
  Complete submission text file 0001104659-25-060714.txt   2613283

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA cbio-20250613.xsd EX-101.SCH 3286
21 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20250613_def.xml EX-101.DEF 26651
22 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20250613_lab.xml EX-101.LAB 36627
23 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20250613_pre.xml EX-101.PRE 25306
37 EXTRACTED XBRL INSTANCE DOCUMENT tm2518203d1_8k_htm.xml XML 5054
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 251057953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)